Abstract
A method for estimating a normal range from a set of immunologic measurements on control subjects when there may be more than one observation per subject is described. The method is nonparametric, makes efficient use of all observations, and is very simple to apply. It is illustrated on a set of 152 CD38 measurements from 58 healthy men.
Full Text
The Full Text of this article is available as a PDF (170.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gelman R., Eudey L. Biostatistical considerations for quality assessment of immunologic measurements used in clinical and longitudinal studies. Clin Immunol Immunopathol. 1989 Jul;52(1):28–37. doi: 10.1016/0090-1229(89)90190-6. [DOI] [PubMed] [Google Scholar]
- Giorgi J. V., Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin Immunol Immunopathol. 1989 Jul;52(1):10–18. doi: 10.1016/0090-1229(89)90188-8. [DOI] [PubMed] [Google Scholar]
- Giorgi J. V., Liu Z., Hultin L. E., Cumberland W. G., Hennessey K., Detels R. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1993 Aug;6(8):904–912. [PubMed] [Google Scholar]
- Harris E. K., DeMets D. L. Estimation of normal ranges and cumulative proportions by transforming observed distributions to gaussian form. Clin Chem. 1972 Jul;18(7):605–612. [PubMed] [Google Scholar]
- Ho H. N., Hultin L. E., Mitsuyasu R. T., Matud J. L., Hausner M. A., Bockstoce D., Chou C. C., O'Rourke S., Taylor J. M., Giorgi J. V. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol. 1993 Apr 1;150(7):3070–3079. [PubMed] [Google Scholar]
- Levacher M., Hulstaert F., Tallet S., Ullery S., Pocidalo J. J., Bach B. A. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol. 1992 Dec;90(3):376–382. doi: 10.1111/j.1365-2249.1992.tb05854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Peddecord K. M., Benenson A. S., Hofherr L. K., Francis D. P., Garfein R. S., Cross G. D., Schalla W. O. Variability of reporting and lack of adherence to consensus guidelines in human T-lymphocyte immunophenotyping reports: results of a case series. J Acquir Immune Defic Syndr. 1993 Jul;6(7):823–830. [PubMed] [Google Scholar]
- Reed A. H., Wu G. T. Evaluation of a transformation method for estimation of normal range. Clin Chem. 1974 May;20(5):576–581. [PubMed] [Google Scholar]
- Salazar-Gonzalez J. F., Moody D. J., Giorgi J. V., Martinez-Maza O., Mitsuyasu R. T., Fahey J. L. Reduced ecto-5'-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CD8 cell immaturity. J Immunol. 1985 Sep;135(3):1778–1785. [PubMed] [Google Scholar]
- Tango T. Estimation of normal ranges of clinical laboratory data. Stat Med. 1986 Jul-Aug;5(4):335–346. doi: 10.1002/sim.4780050406. [DOI] [PubMed] [Google Scholar]
- Taylor J., Afrasiabi R., Fahey J. L., Korns E., Weaver M., Mitsuysau R. Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma. Blood. 1986 Mar;67(3):666–671. [PubMed] [Google Scholar]